Implementation of precision medicine in healthcare—A European perspective

A Stenzinger, EK Moltzen, E Winkler… - Journal of Internal …, 2023 - Wiley Online Library
The technical development of high‐throughput sequencing technologies and the parallel
development of targeted therapies in the last decade have enabled a transition from …

Compressive stresses in cancer: characterization and implications for tumour progression and treatment

JA Linke, LL Munn, RK Jain - Nature Reviews Cancer, 2024 - nature.com
Beyond their many well-established biological aberrations, solid tumours create an
abnormal physical microenvironment that fuels cancer progression and confers treatment …

Precise treatment of pancreatic ductal adenocarcinoma

H Ren - Cancer Letters, 2024 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a highly heterogeneous tumor comprising
pancreatic cancer cells, fibroblasts, immune cells, vascular epithelial cells, and other cells in …

Research progress on the immune microenvironment and immunotherapy in gastric cancer

P Mou, Q Ge, R Sheng, T Zhu, Y Liu… - Frontiers in Immunology, 2023 - frontiersin.org
The tumor microenvironment, particularly the immune microenvironment, plays an
indispensable role in the malignant progression and metastasis of gastric cancer (GC). As …

Hyaluronic acid metabolism and chemotherapy resistance: recent advances and therapeutic potential

Z Liu, P Hou, J Fang, C Shao, Y Shi… - Molecular …, 2024 - Wiley Online Library
Hyaluronic acid (HA) is a major component of the extracellular matrix, providing essential
mechanical scaffolding for cells and, at the same time, mediating essential biochemical …

Current and future immunotherapeutic approaches in pancreatic cancer treatment

P Farhangnia, H Khorramdelazad, H Nickho… - Journal of Hematology & …, 2024 - Springer
Pancreatic cancer is a major cause of cancer-related death, but despondently, the outlook
and prognosis for this resistant type of tumor have remained grim for a long time. Currently, it …

Breaking the stromal barrier in pancreatic cancer: Advances and challenges

M Chakkera, JB Foote, B Farran… - Biochimica et Biophysica …, 2023 - Elsevier
Pancreatic cancer (PC) remains a leading cause of mortality worldwide due to the absence
of early detection methods and the low success rates of traditional therapeutic strategies …

Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC

C Musiu, F Lupo, A Agostini, G Lionetto… - Frontiers in …, 2024 - frontiersin.org
Despite the efforts, pancreatic ductal adenocarcinoma (PDAC) is still highly lethal.
Therapeutic challenges reside in late diagnosis and establishment of peculiar tumor …

Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma

OT Olaoba, M Yang, TI Adelusi, T Maidens, ET Kimchi… - Cancers, 2024 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is characterized by a highly
desmoplastic and extreme immunosuppressive tumor microenvironment (TME), which …

[HTML][HTML] Deciphering Drug Resistance: Investigating the Emerging Role of Hyaluronan Metabolism and Signaling and Tumor Extracellular Matrix in Cancer …

DL Vitale, A Parnigoni, M Viola, E Karousou… - International Journal of …, 2024 - mdpi.com
Hyaluronan (HA) has gained significant attention in cancer research for its role in
modulating chemoresistance. This review aims to elucidate the mechanisms by which HA …